All companies should aspire to do good in the world first, and then success will follow
antibodies that bind ALPP and/or ALPPL2 can be identified by the fact that they bind the same epitope as the "prototypic" antibodies described herein (e.g., M25ADLF, M25ADLFEG, M25ADLFDS, M25FYIA, M25AELFDS M25ADL99P, M25ADL99G, M25ADS95R, M25ADD28G, M25ADS91G, M25ADY93H, M25ADYHSRLF, M25GRITSGFYGDwtLC, M25FSITSGFYGDwtLC, M253018IA, M253018LF, M25AD, M25ADX, ALPPL2rd3_l, ALPPL2rd3_2, M25AGIA, M25AGLF, M25ASIA, M25ASLF, M25ASwt, M25AVIA, M25AVLF, M25ALIA, M25ALLF, M25wtIA, and/or M25wtLF To identify such antibodies, it is not necessary to isolate the subject epitope
You can call us on 07525 207777 email us using [email protected] or use the online form
Disclosures: Shubham Mehta: Nothing to Disclose, Dwarakanathan Vignesh: Nothing to Disclose, Sagnik Biswas: Nothing to Disclose, Shekhar Swaroop: Nothing to Disclose, Bodhisattya Roy Chaudhuri: Nothing to Disclose, Umang Arora: Nothing to Disclose, Arnav Aggarwal: Nothing to Disclose, Ayush Agarwal: Nothing to Disclose, Shalimar: Nothing to Disclose 691 EVALUATING THE IMPACT OF PRE-LIVER TRANSPLANT ACUTE-ON-CHRONIC LIVER FAILURE ON POST-LIVER TRANSPLANT PROGNOSIS IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE David Lee 1 Ki Jung Lee 2 Sharmitha Yerneni 2 Kuntal Bhowmick 3 Youngjae Cha 1 Andrew Yi 1 KeeSeok Lee 2 Gregory Fan 2 Nathalie Urrunaga 1 , 1 University of Maryland School of Medicine, 2 Tufts School of Medicine, 3 Warren Alpert Medical School of Brown University Background: Alcohol- associated liver disease (ALD), the leading cause of chronic liver disease in the developed world, has created a growing need for liver transplantation (LT)
